Update on Retinal Drug Safety with the ReST Committee

Click here to view the webinar entitled "Update on Retinal Drug Safety with the ReST Committee."

The session includes the ReST Committee presenting cases that involve toxicity to the retina, with an additional focus on side effects and possible complications of multiple medications.  The ReST Committee participates in the discussion and answers questions from the audience.  Learn how to report an adverse event when there is a concern related to a retinal drug or device.

Copyright: This program is published by: The American Society of Retina Specialists, 20 N. Wacker Dr., Suite 2030, Chicago, IL 60606


  • Peter Kaiser, MD
  • Caroline Baumal, MD


  • Andre Witkin, MD
  • Roger Goldberg, MD
  • Caroline Baumal, MD
  • Lejla Vajzovic, MD